HC Wainwright & Co. Reiterates Buy on Artelo Biosciences, Maintains $5 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Vernon Bernardino has reiterated a Buy rating on Artelo Biosciences (NASDAQ:ARTL) and maintained a $5 price target on the company's stock.
November 14, 2023 | 11:46 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Artelo Biosciences receives a reiterated Buy rating and a maintained $5 price target from HC Wainwright & Co. analyst Vernon Bernardino.
The reiteration of a Buy rating and the maintenance of a $5 price target by a reputable analyst could lead to increased investor confidence and a potential short-term positive impact on ARTL's stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100